Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review
Paediatr Drugs. 2025 Aug 20. doi: 10.1007/s40272-025-00712-7. Online ahead of print. ABSTRACT BACKGROUND: Anti-interleukin-1 (IL-1) biologic disease-modifying anti-rheumatic drugs are […]
